Elevated lipoprotein (a) and risk of atrial fibrillation: an observational and mendelian randomization study

P Mohammadi-Shemirani, M Chong, S Narula… - Journal of the American …, 2022 - jacc.org
Background Atrial fibrillation (AF) is a cardiac arrhythmia associated with an elevated risk of
stroke, heart failure, and mortality. However, preventative therapies are needed with …

[引用][C] Elevated Lipoprotein (a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study

P Mohammadi-Shemirani, M Chong, S Narula - ascvd-lipidology.knowledgehub …

[HTML][HTML] Elevated Lipoprotein (a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study

P Mohammadi-Shemirani, M Chong, S Narula… - Journal of the American …, 2022 - Elsevier
Background Atrial fibrillation (AF) is a cardiac arrhythmia associated with an elevated risk of
stroke, heart failure, and mortality. However, preventative therapies are needed with …

[引用][C] Elevated Lipoprotein (a) and Risk of Atrial Fibrillation

P Mohammadi-Shemirani, M Chong, S Narula… - Journal of the American …, 2022 - cir.nii.ac.jp
Elevated Lipoprotein(a) and Risk of Atrial Fibrillation | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Elevated Lipoprotein (a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study

P Mohammadi-Shemirani, M Chong… - Journal of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) is a cardiac arrhythmia associated with an elevated risk of
stroke, heart failure, and mortality. However, preventative therapies are needed with …

Elevated Lipoprotein (a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.

P Mohammadi-Shemirani, M Chong… - Journal of the …, 2022 - europepmc.org
Background Atrial fibrillation (AF) is a cardiac arrhythmia associated with an elevated risk of
stroke, heart failure, and mortality. However, preventative therapies are needed with …